Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 258 | 258 | 227 | 286 | 246 |
| Accounts receivable | 48 | -50 | 67 | -120 | 4 |
| Other Working Capital | -217 | -177 | 377 | -23 | -269 |
| Other Operating Activity | -3,972 | -3,936 | -4,494 | -4,937 | -3,786 |
| Operating Cash Flow | $-3,883 | $-3,906 | $-3,823 | $-4,795 | $-3,805 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | 0 | -13 | -37 | -6 |
| Purchase Sale Intangibles | -13 | N/A | 0 | N/A | N/A |
| Other Investing Activity | 64 | 0 | 3 | 0 | 0 |
| Investing Cash Flow | $45 | $0 | $-10 | $-37 | $-6 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | -9 | -4 | N/A | N/A |
| Common Stock Issued | 2,232 | 2,135 | N/A | 14,969 | 43 |
| Common Stock Repurchased | N/A | N/A | -3 | N/A | N/A |
| Other Financing Activity | 0 | -1 | -1 | -396 | -104 |
| Financing Cash Flow | $2,231 | $2,126 | $-8 | $14,573 | $-61 |
| Exchange Rate Effect | -11 | -30 | 256 | 80 | N/A |
| Beginning Cash Position | 4,505 | 6,113 | 8,845 | 1,048 | 4,763 |
| End Cash Position | 2,887 | 4,303 | 5,259 | 10,870 | 890 |
| Net Cash Flow | $-1,607 | $-1,780 | $-3,841 | $9,741 | $-3,872 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,883 | -3,906 | -3,823 | -4,795 | -3,805 |
| Capital Expenditure | -19 | N/A | -13 | -37 | -6 |
| Free Cash Flow | -3,902 | -3,906 | -3,836 | -4,832 | -3,811 |